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Continuous biomanufacturing provides many advantages for the production of therapeutic proteins through 
process integration, automation and intensification. Sanofi currently has developed a robust and integrated 
continuous biomanufacturing platform to achieve improved volumetric productivity and consistent product 
quality. Process intensification reduces the physical footprint as well as capital and operating expenses of 
manufacturing facilities. This presentation is a case study on the implementation of the intensified process for 
commercialization of a biotherapeutic product. 
 
Using a QbD approach, we successfully implemented an intensified perfusion process coupled with continuous 
product capture for a commercial product. High cell densities have resulted in a significant increase in 
volumetric productivity, which allows a substantial footprint reduction and increases flexibility in the commercial 
facility. To understand the impact of process parameters on critical quality attributes (CQAs), univariate and 
multivariate studies were conducted in small scale bioreactors. Mix model repeated measurement was applied 
in the data analysis to incorporate time-dependent information into the predictive model.  This was followed by 
Monte Carlo simulation to determine proven acceptable ranges (PARs) for critical process parameters in 
support of process control strategy (PCS). Facilitated by computational fluid dynamics (CFD) simulation, we 
successfully scaled up the process to commercial scale. In this presentation, challenges associated with 
application of QbD approach for a perfusion process and the advantages of an intensified perfusion process will 
be discussed. 
 
 
